Annual CFO
-$79.49 M
-$33.37 M-72.35%
December 31, 2023
Summary
- As of February 26, 2025, GPCR annual cash flow from operations is -$79.49 million, with the most recent change of -$33.37 million (-72.35%) on December 31, 2023.
- During the last 3 years, GPCR annual CFO has fallen by -$65.20 million (-456.52%).
- GPCR annual CFO is now -456.52% below its all-time high of -$14.28 million, reached on December 1, 2020.
Performance
GPCR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$19.70 M
+$6.70 M+25.37%
September 30, 2024
Summary
- As of February 26, 2025, GPCR quarterly cash flow from operations is -$19.70 million, with the most recent change of +$6.70 million (+25.37%) on September 30, 2024.
- Over the past year, GPCR quarterly CFO has increased by +$861.00 thousand (+4.19%).
- GPCR quarterly CFO is now -95.11% below its all-time high of -$10.10 million, reached on June 1, 2022.
Performance
GPCR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$101.90 M
+$861.00 K+0.84%
September 30, 2024
Summary
- As of February 26, 2025, GPCR TTM cash flow from operations is -$101.90 million, with the most recent change of +$861.00 thousand (+0.84%) on September 30, 2024.
- Over the past year, GPCR TTM CFO has dropped by -$32.11 million (-46.02%).
- GPCR TTM CFO is now -653.79% below its all-time high of -$13.52 million, reached on March 1, 2022.
Performance
GPCR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GPCR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.3% | +4.2% | -46.0% |
| 3 y3 years | -456.5% | +4.2% | -46.0% |
| 5 y5 years | -456.5% | +4.2% | -46.0% |
GPCR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -147.2% | at low | -95.1% | +42.2% | -653.8% | +0.8% |
| 5 y | 5-year | -456.5% | at low | -95.1% | +42.2% | -653.8% | +0.8% |
| alltime | all time | -456.5% | at low | -95.1% | +42.2% | -653.8% | +0.8% |
Structure Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$19.70 M(-25.4%) | -$101.90 M(-0.8%) |
| Jun 2024 | - | -$26.39 M(-22.6%) | -$102.76 M(+10.2%) |
| Mar 2024 | - | -$34.08 M(+56.8%) | -$93.26 M(+17.3%) |
| Dec 2023 | -$79.49 M | -$21.73 M(+5.7%) | -$79.49 M(+13.9%) |
| Sep 2023 | - | -$20.56 M(+21.7%) | -$69.78 M(+16.9%) |
| Jun 2023 | - | -$16.89 M(-16.8%) | -$59.71 M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$20.31 M(+68.9%) | -$52.91 M(+14.7%) |
| Dec 2022 | -$46.12 M(+43.4%) | -$12.03 M(+14.7%) | -$46.12 M(+35.3%) |
| Sep 2022 | - | -$10.48 M(+3.8%) | -$34.09 M(+44.4%) |
| Jun 2022 | - | -$10.10 M(-25.3%) | -$23.61 M(+74.7%) |
| Mar 2022 | - | -$13.52 M | -$13.52 M |
| Dec 2021 | -$32.16 M(+125.2%) | - | - |
| Dec 2020 | -$14.28 M | - | - |
FAQ
- What is Structure Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Structure Therapeutics?
- What is Structure Therapeutics annual CFO year-on-year change?
- What is Structure Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Structure Therapeutics?
- What is Structure Therapeutics quarterly CFO year-on-year change?
- What is Structure Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Structure Therapeutics?
- What is Structure Therapeutics TTM CFO year-on-year change?
What is Structure Therapeutics annual cash flow from operations?
The current annual CFO of GPCR is -$79.49 M
What is the all time high annual CFO for Structure Therapeutics?
Structure Therapeutics all-time high annual cash flow from operations is -$14.28 M
What is Structure Therapeutics annual CFO year-on-year change?
Over the past year, GPCR annual cash flow from operations has changed by -$33.37 M (-72.35%)
What is Structure Therapeutics quarterly cash flow from operations?
The current quarterly CFO of GPCR is -$19.70 M
What is the all time high quarterly CFO for Structure Therapeutics?
Structure Therapeutics all-time high quarterly cash flow from operations is -$10.10 M
What is Structure Therapeutics quarterly CFO year-on-year change?
Over the past year, GPCR quarterly cash flow from operations has changed by +$861.00 K (+4.19%)
What is Structure Therapeutics TTM cash flow from operations?
The current TTM CFO of GPCR is -$101.90 M
What is the all time high TTM CFO for Structure Therapeutics?
Structure Therapeutics all-time high TTM cash flow from operations is -$13.52 M
What is Structure Therapeutics TTM CFO year-on-year change?
Over the past year, GPCR TTM cash flow from operations has changed by -$32.11 M (-46.02%)